NMT Group PLC
9 January 2001
9 January 2001
Appointment of President and Relocation of US Office
Livingston, Scotland - NMT Group PLC ('NMT'), the manufacturer of retractable
devices to prevent needlestick injury, today announces the appointment of
Steve Czick as President of NMT Inc., NMT's US subsidiary.
Stephen J. Czick, 51, has over 25 years medical device experience with Johnson
& Johnson, and was most recently Vice President, World-wide Sales & Marketing
for the Casting Products Division of DePuy Orthopaedics, a Johnson & Johnson
company. The majority of his career has been spent in senior sales and
marketing positions at Ethicon Inc., Johnson & Johnson Hospital Services and
Johnson & Johnson Orthopaedics. As President of NMT Inc., Steve will be
responsible for all operational activity in North America, Latin America and
the Asia Pacific Rim.
NMT also announces that it intends to relocate the Group's US activities from
Zionsville, Indiana, to Massachusetts during 2001.
Commenting on the appointment, Roy Smith, Chief Executive Officer, said:
'Steve's wealth of sales and marketing experience will be a tremendous asset
to NMT. The US remains the most important market for NMT's technology and
Steve's experience and understanding of the US medical devices market will be
invaluable to the Group's rapid development.'
- Ends -
Enquiries:
NMT Group PLC Tel: 01506 445000
Roy Smith
Financial Dynamics Tel: 0207 831 3113
Sophie Pender-Cudlip/Fiona Noblet
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.